{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T17:07:41Z","timestamp":1782320861122,"version":"3.54.5"},"reference-count":20,"publisher":"American Academy of Pediatrics (AAP)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[1998,4,1]]},"abstract":"<jats:p>Objective.\u2003To evaluate the short- and long-term effects of treatment of symptomatic chronic adenotonsillar hypertrophy (CATH) with a 30-day course of amoxicillin\/clavulanate potassium (AMOX\/CLAV).<\/jats:p><jats:p>Patients.\u2003Children 2 to 16 years of age with obstructive symptoms attributable to CATH, who did not have a history of recurrent adenotonsillitis.<\/jats:p><jats:p>Design.\u2003A prospective, randomized, double-blinded, placebo-controlled trial.<\/jats:p><jats:p>Setting.\u2003Ambulatory clinic of a tertiary care hospital.<\/jats:p><jats:p>Intervention.\u2003Patients were randomly treated with 30-day courses of either placebo (PLAC) or AMOX\/CLAV (40 mg\/kg in 3 divided doses daily).<\/jats:p><jats:p>Outcome Measures.\u2003Patients' signs and symptoms were assessed by physical examination and by both physician and parental forced-choice questionnaires 1, 3, and 24 months after treatment. The decision to proceed to surgery or to continue expectant management was made for all patients by the same physician, based on reported symptoms and physical findings.<\/jats:p><jats:p>Results.\u2003Treatment with a 30-day course of AMOX\/CLAV significantly reduced the need for surgery in the short term compared with PLAC (37.5% vs 62.7%) at 1-month follow-up). The reduced need for surgery in the AMOX\/CLAV-treated group persisted at 3 months (AMOX\/CLAV 54.5% vs PLAC 85.7%) and 24 months (AMOX\/CLAV 83.3% vs PLAC 98.0%).<\/jats:p><jats:p>Conclusions.\u2003A 30-day course of AMOX\/CLAV significantly reduces the need for surgery in children with obstructive adenotonsillar hypertrophy at 1-month follow-up. This relative reduction persists at 3 and 24 months posttreatment, although the absolute percentages of patients requiring surgery increased in both groups as time after treatment increased. The reduction in symptoms in AMOX\/CLAV-treated patients is modest but significant even in long-term follow-up. The precise role of this treatment for CATH is yet to be determined; however, our results suggest that a 30-day course of AMOX\/CLAV can be used in situations when a temporary relief in symptoms is desirable or surgery would incur unacceptable risk.<\/jats:p>","DOI":"10.1542\/peds.101.4.675","type":"journal-article","created":{"date-parts":[[2004,8,13]],"date-time":"2004-08-13T23:44:32Z","timestamp":1092440672000},"page":"675-681","source":"Crossref","is-referenced-by-count":37,"title":["Treatment of Symptomatic Chronic Adenotonsillar Hypertrophy With Amoxicillin\/Clavulanate Potassium: Short- and Long-term Results"],"prefix":"10.1542","volume":"101","author":[{"given":"Anthony P.","family":"Sclafani","sequence":"first","affiliation":[{"name":"From the Department of Otolaryngology\u2014Head & Neck Surgery and the"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey","family":"Ginsburg","sequence":"additional","affiliation":[{"name":"From the Department of Otolaryngology\u2014Head & Neck Surgery and the"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahendra K.","family":"Shah","sequence":"additional","affiliation":[{"name":"Division of Microbiology, Department of Pathology, New York Eye & Ear Infirmary, New York, New York, and New York Medical College, Valhalla, New York."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jay N.","family":"Dolitsky","sequence":"additional","affiliation":[{"name":"From the Department of Otolaryngology\u2014Head & Neck Surgery and the"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"417","published-online":{"date-parts":[[1998,4,1]]},"reference":[{"key":"2021121019325875400_B1","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1001\/archotol.1986.03780080073017","article-title":"Ear, nose, and throat operations in the United States, 1979 to 1984.","volume":"112","author":"Rutkow","year":"1986","journal-title":"Arch Otolaryngol Head Neck Surg."},{"key":"2021121019325875400_B2","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/S0030-6665(20)31650-9","article-title":"Evaluation of coagulation disorders in patients with diseases of Waldeyer's ring.","volume":"20","author":"Hutchison","year":"1987","journal-title":"Otolaryngol Clin North Am."},{"key":"2021121019325875400_B3","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1288\/00005537-198801000-00019","article-title":"The immunology of tonsils in children: the effect of bacterial load on the presence of B- and T- cell subsets.","volume":"98","author":"Brodsky","year":"1988","journal-title":"Laryngoscope."},{"key":"2021121019325875400_B4","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1288\/00005537-198810000-00006","article-title":"The role of Haemophilus influenzae in the pathogenesis of tonsillar hypertrophy in children.","volume":"98","author":"Brodsky","year":"1988","journal-title":"Laryngoscope."},{"key":"2021121019325875400_B5","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1001\/archotol.1993.01880200021003","article-title":"Bacteriology and immunology of normal and diseased adenoids in children.","volume":"119","author":"Brodsky","year":"1993","journal-title":"Arch Otolaryngol Head Neck Surg."},{"key":"2021121019325875400_B6","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1288\/00005537-199309000-00013","article-title":"Effect of specific bacteria on lymphocyte proliferation in diseased and nondiseased tonsils.","volume":"103","author":"Koch","year":"1993","journal-title":"Laryngoscope."},{"key":"2021121019325875400_B7","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1177\/019459989310900410","article-title":"Are thymus-derived lymphocytes (T cells) defective in the nasopharyngeal and palatine tonsils of children?","volume":"109","author":"Bernstein","year":"1993","journal-title":"Otolaryngol Head Neck Surg."},{"key":"2021121019325875400_B8"},{"key":"2021121019325875400_B9","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/S0030-6665(20)30509-0","article-title":"The history of tonsil and adenoid surgery.","volume":"20","author":"Curtin","year":"1987","journal-title":"Otolaryngol Clin North Am."},{"key":"2021121019325875400_B10","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1177\/019459988609400412","article-title":"Relief of upper airway obstruction by adenotonsillectomy.","volume":"94","author":"Potsic","year":"1986","journal-title":"Otolaryngol Head Neck Surg."},{"key":"2021121019325875400_B11","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1016\/S0030-6665(20)31243-3","article-title":"Sleep disorders and airway obstruction in children.","volume":"23","author":"Potsic","year":"1990","journal-title":"Otolaryngol Clin North Am."},{"key":"2021121019325875400_B12","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1002\/lary.1982.92.6.650","article-title":"Adenotonsillar hypertrophy and upper airway obstruction in evolutionary perspective.","volume":"92","author":"Grundfast","year":"1982","journal-title":"Laryngoscope."},{"key":"2021121019325875400_B13","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/0165-5876(87)90088-7","article-title":"Postoperative complication following tonsillectomy and adenoidectomy\u2014who is at risk?","volume":"13","author":"Richmond","year":"1987","journal-title":"Int J Pediatr Otorhinolaryngol."},{"key":"2021121019325875400_B14","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1001\/archotol.1988.01860190067025","article-title":"Microbiology of the tonsils and adenoids in a pediatric population.","volume":"114","author":"DeDio","year":"1988","journal-title":"Arch Otolaryngol Head Neck Surg."},{"key":"2021121019325875400_B15","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/0165-5876(91)90057-I","article-title":"The relationship of tonsil bacterial concentration to surface and core cultures in chronic tonsillar disease in children.","volume":"21","author":"Brodsky","year":"1991","journal-title":"Int J Pediatr Otorhinolarngol."},{"key":"2021121019325875400_B16","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1288\/00005537-198103000-00005","article-title":"Aerobic and anaerobic bacteriology of adenoids in children: a comparison between patients with chronic adenotonsillitis and adenoid hypertrophy.","volume":"91","author":"Brook","year":"1981","journal-title":"Laryngoscope."},{"key":"2021121019325875400_B17","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1001\/archotol.1989.01860300075021","article-title":"Microbiology of obstructive tonsillar hypertrophy and recurrent tonsillitis.","volume":"115","author":"Kielmovitch","year":"1989","journal-title":"Arch Otolaryngol Head Neck Surg."},{"key":"2021121019325875400_B18","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1177\/000348949510400810","article-title":"Quantitative bacteriology of tonsils removed from children with tonsillitis hypertrophy and recurrent tonsillitis with and without hypertrophy.","volume":"104","author":"Kuhn","year":"1995","journal-title":"Ann Otol Rhinol Laryngol."},{"key":"2021121019325875400_B19","doi-asserted-by":"crossref","first-page":"274","DOI":"10.3109\/00016489009122548","article-title":"Amoxicillin\/clavulanate treatment in secretory otitis media. Bacteriological findings in the nasopharynx.","volume":"110","author":"Balle","year":"1990","journal-title":"Acta Otolaryngol."},{"key":"2021121019325875400_B20","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1097\/00006454-199705000-00002","article-title":"Equivalent efficacy and reduced occurrence of diarrhea from a new formulation of amoxicillin\/clavulanate potassium (Augmentin) for treatment of acute otitis media in children.","volume":"16","author":"Hoberman","year":"1997","journal-title":"Pediatr Infect Dis J."}],"container-title":["Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/publications.aap.org\/pediatrics\/article-pdf\/101\/4\/675\/828301\/675.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/publications.aap.org\/pediatrics\/article-pdf\/101\/4\/675\/828301\/675.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,14]],"date-time":"2024-01-14T05:06:35Z","timestamp":1705208795000},"score":1,"resource":{"primary":{"URL":"https:\/\/publications.aap.org\/pediatrics\/article\/101\/4\/675\/62017\/Treatment-of-Symptomatic-Chronic-Adenotonsillar"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1998,4,1]]},"references-count":20,"journal-issue":{"issue":"4","published-online":{"date-parts":[[1998,4,1]]},"published-print":{"date-parts":[[1998,4,1]]}},"URL":"https:\/\/doi.org\/10.1542\/peds.101.4.675","relation":{},"ISSN":["1098-4275","0031-4005"],"issn-type":[{"value":"1098-4275","type":"electronic"},{"value":"0031-4005","type":"print"}],"subject":[],"published":{"date-parts":[[1998,4,1]]}}}